Shanghai Kaibao Pharmaceutical (300039) — Cash Flow Reinvestment Rate
Shanghai Kaibao Pharmaceutical (300039) has a Cash Flow Reinvestment Rate of 0.02x as of September 2025, reinvesting CN¥3.37 Million (capex CN¥3.37 Million ) from operating cash flow of CN¥190.98 Million. Check Shanghai Kaibao Pharmaceutical cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Kaibao Pharmaceutical Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Shanghai Kaibao Pharmaceutical across 19 annual periods. Explore Shanghai Kaibao Pharmaceutical strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Shanghai Kaibao Pharmaceutical (2006–2024)
Year-by-year capital reinvestment analysis for Shanghai Kaibao Pharmaceutical. For live market cap and broader valuation context, see 300039 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.52x | CN¥145.48 Million | CN¥278.95 Million | CN¥140.52 Million | ▼ -12.4% |
| 2023 | 0.60x | CN¥227.71 Million | CN¥382.66 Million | CN¥29.08 Million | ▼ -29.3% |
| 2022 | 0.84x | CN¥316.99 Million | CN¥376.42 Million | CN¥31.62 Million | ▲ +46.5% |
| 2021 | 0.57x | CN¥72.48 Million | CN¥126.08 Million | CN¥42.55 Million | ▲ +73.0% |
| 2020 | 0.33x | CN¥83.28 Million | CN¥250.65 Million | CN¥13.94 Million | ▼ -82.2% |
| 2019 | 1.86x | CN¥622.91 Million | CN¥334.09 Million | CN¥15.46 Million | ▲ +155.3% |
| 2018 | 0.73x | CN¥191.63 Million | CN¥262.36 Million | CN¥26.07 Million | ▼ -25.3% |
| 2017 | 0.98x | CN¥240.28 Million | CN¥245.76 Million | CN¥49.24 Million | ▼ -29.5% |
| 2016 | 1.39x | CN¥436.47 Million | CN¥314.88 Million | CN¥27.03 Million | ▲ +330.4% |
| 2015 | 0.32x | CN¥105.34 Million | CN¥327.08 Million | CN¥50.40 Million | ▲ +32.3% |
| 2014 | 0.24x | CN¥68.74 Million | CN¥282.38 Million | CN¥68.74 Million | ▼ -44.4% |
| 2013 | 0.44x | CN¥118.28 Million | CN¥270.23 Million | CN¥118.28 Million | ▲ +104.0% |
| 2012 | 0.21x | CN¥52.21 Million | CN¥243.32 Million | CN¥52.21 Million | ▼ -69.4% |
| 2011 | 0.70x | CN¥68.85 Million | CN¥98.31 Million | CN¥68.85 Million | ▼ -72.8% |
| 2010 | 2.58x | CN¥51.01 Million | CN¥19.79 Million | CN¥51.01 Million | ▲ +8.1% |
| 2009 | 2.38x | CN¥125.70 Million | CN¥52.74 Million | CN¥125.70 Million | ▲ +294.9% |
| 2008 | 0.60x | CN¥11.28 Million | CN¥18.70 Million | CN¥11.28 Million | ▲ +204.1% |
| 2007 | 0.20x | CN¥4.62 Million | CN¥23.27 Million | CN¥4.62 Million | ▼ -66.7% |
| 2006 | 0.60x | CN¥11.74 Million | CN¥19.70 Million | CN¥11.74 Million | — |